

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of protein activation cascade (GO:2000257) | 8.39925376 |
| 2 | regulation of complement activation (GO:0030449) | 8.20224455 |
| 3 | negative regulation of fibrinolysis (GO:0051918) | 8.12551243 |
| 4 | regulation of fibrinolysis (GO:0051917) | 7.77649226 |
| 5 | complement activation, alternative pathway (GO:0006957) | 7.59778116 |
| 6 | exogenous drug catabolic process (GO:0042738) | 7.27423925 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 7.14993845 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.14993845 |
| 9 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.88398862 |
| 10 | protein carboxylation (GO:0018214) | 6.88398862 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 6.64013504 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.64013504 |
| 13 | epoxygenase P450 pathway (GO:0019373) | 6.53141873 |
| 14 | regulation of apoptotic cell clearance (GO:2000425) | 6.42769178 |
| 15 | drug catabolic process (GO:0042737) | 6.36542004 |
| 16 | omega-hydroxylase P450 pathway (GO:0097267) | 6.20989244 |
| 17 | blood coagulation, intrinsic pathway (GO:0007597) | 5.97557634 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.73546415 |
| 19 | very-low-density lipoprotein particle assembly (GO:0034379) | 5.56239251 |
| 20 | intestinal cholesterol absorption (GO:0030299) | 5.54528615 |
| 21 | regulation of plasminogen activation (GO:0010755) | 5.43064206 |
| 22 | plasma lipoprotein particle remodeling (GO:0034369) | 5.34392768 |
| 23 | protein-lipid complex remodeling (GO:0034368) | 5.34392768 |
| 24 | macromolecular complex remodeling (GO:0034367) | 5.34392768 |
| 25 | complement activation, classical pathway (GO:0006958) | 5.34247405 |
| 26 | protein activation cascade (GO:0072376) | 5.21825648 |
| 27 | negative regulation of protein activation cascade (GO:2000258) | 5.20372551 |
| 28 | plasma lipoprotein particle assembly (GO:0034377) | 5.12332631 |
| 29 | fibrinolysis (GO:0042730) | 5.09903219 |
| 30 | low-density lipoprotein particle remodeling (GO:0034374) | 5.06266963 |
| 31 | cholesterol efflux (GO:0033344) | 4.97282938 |
| 32 | regulation of humoral immune response (GO:0002920) | 4.90119305 |
| 33 | negative regulation of sterol transport (GO:0032372) | 4.85222613 |
| 34 | negative regulation of cholesterol transport (GO:0032375) | 4.85222613 |
| 35 | complement activation (GO:0006956) | 4.81137697 |
| 36 | regulation of cholesterol esterification (GO:0010872) | 4.80173656 |
| 37 | high-density lipoprotein particle remodeling (GO:0034375) | 4.63502192 |
| 38 | urea metabolic process (GO:0019627) | 4.62516422 |
| 39 | plasma lipoprotein particle organization (GO:0071827) | 4.62365050 |
| 40 | acute-phase response (GO:0006953) | 4.62314552 |
| 41 | aromatic amino acid family catabolic process (GO:0009074) | 4.61350225 |
| 42 | opsonization (GO:0008228) | 4.60365781 |
| 43 | protein-lipid complex assembly (GO:0065005) | 4.58285291 |
| 44 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.53263022 |
| 45 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.53263022 |
| 46 | ethanol oxidation (GO:0006069) | 4.43318447 |
| 47 | protein-lipid complex subunit organization (GO:0071825) | 4.35913021 |
| 48 | reverse cholesterol transport (GO:0043691) | 4.32500618 |
| 49 | negative regulation of complement activation (GO:0045916) | 4.29177510 |
| 50 | negative regulation of hemostasis (GO:1900047) | 4.28302536 |
| 51 | negative regulation of blood coagulation (GO:0030195) | 4.28302536 |
| 52 | glutamate metabolic process (GO:0006536) | 4.25004686 |
| 53 | glyoxylate metabolic process (GO:0046487) | 4.17852580 |
| 54 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.16692619 |
| 55 | nitrogen cycle metabolic process (GO:0071941) | 4.15882290 |
| 56 | drug metabolic process (GO:0017144) | 4.06995264 |
| 57 | urea cycle (GO:0000050) | 4.03139147 |
| 58 | tyrosine metabolic process (GO:0006570) | 4.02365893 |
| 59 | positive regulation of blood coagulation (GO:0030194) | 3.98006863 |
| 60 | positive regulation of hemostasis (GO:1900048) | 3.98006863 |
| 61 | acylglycerol homeostasis (GO:0055090) | 3.97491358 |
| 62 | triglyceride homeostasis (GO:0070328) | 3.97491358 |
| 63 | bile acid metabolic process (GO:0008206) | 3.96891271 |
| 64 | bile acid biosynthetic process (GO:0006699) | 3.95699469 |
| 65 | plasma lipoprotein particle clearance (GO:0034381) | 3.94746356 |
| 66 | negative regulation of coagulation (GO:0050819) | 3.91399746 |
| 67 | cellular glucuronidation (GO:0052695) | 3.90475593 |
| 68 | phospholipid efflux (GO:0033700) | 3.89962353 |
| 69 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.86929473 |
| 70 | cytolysis (GO:0019835) | 3.84290912 |
| 71 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.84149103 |
| 72 | lipoprotein metabolic process (GO:0042157) | 3.83989746 |
| 73 | serine family amino acid catabolic process (GO:0009071) | 3.80488816 |
| 74 | regulation of cholesterol homeostasis (GO:2000188) | 3.74845929 |
| 75 | imidazole-containing compound metabolic process (GO:0052803) | 3.73553567 |
| 76 | positive regulation of extracellular matrix organization (GO:1903055) | 3.72145107 |
| 77 | negative regulation of wound healing (GO:0061045) | 3.70938684 |
| 78 | ethanol metabolic process (GO:0006067) | 3.66621936 |
| 79 | glucuronate metabolic process (GO:0019585) | 3.65996574 |
| 80 | uronic acid metabolic process (GO:0006063) | 3.65996574 |
| 81 | intestinal absorption (GO:0050892) | 3.64954358 |
| 82 | positive regulation of coagulation (GO:0050820) | 3.63746313 |
| 83 | bile acid and bile salt transport (GO:0015721) | 3.55835616 |
| 84 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 3.54946639 |
| 85 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 3.54946639 |
| 86 | proline metabolic process (GO:0006560) | 3.54388878 |
| 87 | regulation of triglyceride catabolic process (GO:0010896) | 3.52668108 |
| 88 | response to mercury ion (GO:0046689) | 3.48353931 |
| 89 | negative regulation of lipase activity (GO:0060192) | 3.47204670 |
| 90 | regulation of bile acid biosynthetic process (GO:0070857) | 3.41082186 |
| 91 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.37809868 |
| 92 | cholesterol homeostasis (GO:0042632) | 3.36474672 |
| 93 | negative regulation of humoral immune response (GO:0002921) | 3.35327055 |
| 94 | amino-acid betaine metabolic process (GO:0006577) | 3.34366389 |
| 95 | sterol homeostasis (GO:0055092) | 3.31705145 |
| 96 | acute inflammatory response (GO:0002526) | 3.30811724 |
| 97 | drug transmembrane transport (GO:0006855) | 3.30370915 |
| 98 | regulation of acute inflammatory response (GO:0002673) | 3.29322033 |
| 99 | regulation of cholesterol metabolic process (GO:0090181) | 3.29175698 |
| 100 | oxidative demethylation (GO:0070989) | 3.25554903 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.86275125 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.80481523 |
| 3 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.94905572 |
| 4 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.91011339 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.41595628 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.22685933 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.81388425 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.79626033 |
| 9 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.51187696 |
| 10 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.44179998 |
| 11 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 3.05991987 |
| 12 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.58078930 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.57869364 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.29070525 |
| 15 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17791212 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14894346 |
| 17 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.11752334 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.04101872 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91512260 |
| 20 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.91185957 |
| 21 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.74135093 |
| 22 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.72759875 |
| 23 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.67034158 |
| 24 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.66654884 |
| 25 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.61200034 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.52356673 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50632192 |
| 28 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.47375732 |
| 29 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45002195 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.41292411 |
| 31 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.34515985 |
| 32 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33883492 |
| 33 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33214816 |
| 34 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32988154 |
| 35 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.32087321 |
| 36 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26660293 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.22359871 |
| 38 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.19787986 |
| 39 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.15331080 |
| 40 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14384564 |
| 41 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.13091215 |
| 42 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.11355059 |
| 43 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09202917 |
| 44 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08913644 |
| 45 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07932655 |
| 46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05060590 |
| 47 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.03941295 |
| 48 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03940999 |
| 49 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.01673106 |
| 50 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.00643106 |
| 51 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.00587432 |
| 52 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.98937479 |
| 53 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.95043705 |
| 54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94831496 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94458338 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.93644293 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.92669508 |
| 58 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.91035265 |
| 59 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.90934063 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.89206984 |
| 61 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88707029 |
| 62 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.88675455 |
| 63 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.86414102 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.86334404 |
| 65 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.85863962 |
| 66 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85515568 |
| 67 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.84981022 |
| 68 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84964335 |
| 69 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.84524852 |
| 70 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.83645122 |
| 71 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.83486195 |
| 72 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.79485224 |
| 73 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.79260396 |
| 74 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77394033 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.77127013 |
| 76 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.76632388 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75846235 |
| 78 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75374592 |
| 79 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.74174819 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73993269 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.71863632 |
| 82 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.71160402 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.70461229 |
| 84 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.69651581 |
| 85 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69600527 |
| 86 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.68920734 |
| 87 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.68540786 |
| 88 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.68034106 |
| 89 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.67932230 |
| 90 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.67413740 |
| 91 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.64663693 |
| 92 | KDM2B_26808549_Chip-Seq_K562_Human | 0.64164538 |
| 93 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.61933650 |
| 94 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.61933650 |
| 95 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.61823346 |
| 96 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.61783795 |
| 97 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.60103323 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.60023985 |
| 99 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.59949854 |
| 100 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59421295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.70910297 |
| 2 | MP0005360_urolithiasis | 5.89598524 |
| 3 | MP0005365_abnormal_bile_salt | 5.71497748 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 5.22740394 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.71582303 |
| 6 | MP0003195_calcinosis | 4.67801343 |
| 7 | MP0003252_abnormal_bile_duct | 3.99442830 |
| 8 | MP0001666_abnormal_nutrient_absorption | 3.70192944 |
| 9 | MP0010329_abnormal_lipoprotein_level | 3.29946290 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.87174260 |
| 11 | MP0003868_abnormal_feces_composition | 2.71757746 |
| 12 | MP0003122_maternal_imprinting | 2.49045987 |
| 13 | MP0010368_abnormal_lymphatic_system | 2.36460245 |
| 14 | MP0005332_abnormal_amino_acid | 2.05360428 |
| 15 | MP0009840_abnormal_foam_cell | 2.00145141 |
| 16 | MP0000609_abnormal_liver_physiology | 1.91161196 |
| 17 | MP0005670_abnormal_white_adipose | 1.89710169 |
| 18 | MP0003191_abnormal_cellular_cholesterol | 1.81891675 |
| 19 | MP0000566_synostosis | 1.79630916 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.72071512 |
| 21 | MP0005408_hypopigmentation | 1.65122085 |
| 22 | MP0001915_intracranial_hemorrhage | 1.57352227 |
| 23 | MP0005058_abnormal_lysosome_morphology | 1.56511040 |
| 24 | MP0002132_abnormal_respiratory_system | 1.50605570 |
| 25 | MP0002089_abnormal_postnatal_growth/wei | 1.41267150 |
| 26 | MP0003172_abnormal_lysosome_physiology | 1.29585757 |
| 27 | MP0001661_extended_life_span | 1.29455376 |
| 28 | MP0005409_darkened_coat_color | 1.28462448 |
| 29 | MP0005451_abnormal_body_composition | 1.24914340 |
| 30 | MP0009780_abnormal_chondrocyte_physiolo | 1.17666295 |
| 31 | MP0002876_abnormal_thyroid_physiology | 1.17591239 |
| 32 | MP0004272_abnormal_basement_membrane | 1.14450102 |
| 33 | MP0003123_paternal_imprinting | 1.11369454 |
| 34 | MP0000598_abnormal_liver_morphology | 1.09949325 |
| 35 | MP0003879_abnormal_hair_cell | 1.05413944 |
| 36 | MP0004019_abnormal_vitamin_homeostasis | 1.03574511 |
| 37 | MP0005257_abnormal_intraocular_pressure | 1.00117636 |
| 38 | MP0005319_abnormal_enzyme/_coenzyme | 0.99289523 |
| 39 | MP0009643_abnormal_urine_homeostasis | 0.93789407 |
| 40 | MP0000604_amyloidosis | 0.92734580 |
| 41 | MP0001764_abnormal_homeostasis | 0.90911251 |
| 42 | MP0006054_spinal_hemorrhage | 0.90487851 |
| 43 | MP0005167_abnormal_blood-brain_barrier | 0.90159676 |
| 44 | MP0005636_abnormal_mineral_homeostasis | 0.89506376 |
| 45 | MP0008438_abnormal_cutaneous_collagen | 0.87268365 |
| 46 | MP0002933_joint_inflammation | 0.86305747 |
| 47 | MP0005023_abnormal_wound_healing | 0.86027000 |
| 48 | MP0003183_abnormal_peptide_metabolism | 0.85724462 |
| 49 | MP0003690_abnormal_glial_cell | 0.85592816 |
| 50 | MP0003656_abnormal_erythrocyte_physiolo | 0.85342904 |
| 51 | MP0003329_amyloid_beta_deposits | 0.85088562 |
| 52 | MP0009642_abnormal_blood_homeostasis | 0.83197563 |
| 53 | MP0000639_abnormal_adrenal_gland | 0.83178813 |
| 54 | MP0009697_abnormal_copulation | 0.82200267 |
| 55 | MP0002971_abnormal_brown_adipose | 0.80611841 |
| 56 | MP0003566_abnormal_cell_adhesion | 0.79799839 |
| 57 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.75998392 |
| 58 | MP0003950_abnormal_plasma_membrane | 0.72731901 |
| 59 | MP0004264_abnormal_extraembryonic_tissu | 0.71839151 |
| 60 | MP0000920_abnormal_myelination | 0.70990464 |
| 61 | MP0001756_abnormal_urination | 0.70464765 |
| 62 | MP0002249_abnormal_larynx_morphology | 0.67436978 |
| 63 | MP0002282_abnormal_trachea_morphology | 0.67218612 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 0.64533487 |
| 65 | MP0005164_abnormal_response_to | 0.64483741 |
| 66 | MP0002078_abnormal_glucose_homeostasis | 0.63895359 |
| 67 | MP0005464_abnormal_platelet_physiology | 0.61406209 |
| 68 | MP0008469_abnormal_protein_level | 0.59875181 |
| 69 | MP0002909_abnormal_adrenal_gland | 0.59614395 |
| 70 | MP0005220_abnormal_exocrine_pancreas | 0.59517705 |
| 71 | MP0005076_abnormal_cell_differentiation | 0.59490811 |
| 72 | MP0009763_increased_sensitivity_to | 0.58437477 |
| 73 | MP0009384_cardiac_valve_regurgitation | 0.57552831 |
| 74 | MP0002168_other_aberrant_phenotype | 0.56976671 |
| 75 | MP0004782_abnormal_surfactant_physiolog | 0.56008293 |
| 76 | MP0009115_abnormal_fat_cell | 0.55532044 |
| 77 | MP0001270_distended_abdomen | 0.54578852 |
| 78 | MP0004043_abnormal_pH_regulation | 0.53813111 |
| 79 | MP0003632_abnormal_nervous_system | 0.52551960 |
| 80 | MP0004883_abnormal_blood_vessel | 0.50877525 |
| 81 | MP0000678_abnormal_parathyroid_gland | 0.50121641 |
| 82 | MP0005448_abnormal_energy_balance | 0.50000923 |
| 83 | MP0003300_gastrointestinal_ulcer | 0.48572429 |
| 84 | MP0003115_abnormal_respiratory_system | 0.48505883 |
| 85 | MP0000249_abnormal_blood_vessel | 0.47532805 |
| 86 | MP0003878_abnormal_ear_physiology | 0.47024595 |
| 87 | MP0005377_hearing/vestibular/ear_phenot | 0.47024595 |
| 88 | MP0000003_abnormal_adipose_tissue | 0.46993596 |
| 89 | MP0005376_homeostasis/metabolism_phenot | 0.45767694 |
| 90 | MP0008004_abnormal_stomach_pH | 0.42995596 |
| 91 | MP0005083_abnormal_biliary_tract | 0.42023213 |
| 92 | MP0003953_abnormal_hormone_level | 0.41509593 |
| 93 | MP0000858_altered_metastatic_potential | 0.41490873 |
| 94 | MP0002128_abnormal_blood_circulation | 0.41394763 |
| 95 | MP0002896_abnormal_bone_mineralization | 0.41200308 |
| 96 | MP0003075_altered_response_to | 0.39662219 |
| 97 | MP0005395_other_phenotype | 0.39369561 |
| 98 | MP0003638_abnormal_response/metabolism_ | 0.38172340 |
| 99 | MP0003011_delayed_dark_adaptation | 0.37930929 |
| 100 | MP0005084_abnormal_gallbladder_morpholo | 0.36627788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 9.22744117 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.16727290 |
| 3 | Abnormality of complement system (HP:0005339) | 7.27068343 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.80646933 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.60972050 |
| 6 | Glomerulonephritis (HP:0000099) | 6.42633683 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.41232524 |
| 8 | Joint hemorrhage (HP:0005261) | 6.40996027 |
| 9 | Systemic lupus erythematosus (HP:0002725) | 6.24222901 |
| 10 | Conjugated hyperbilirubinemia (HP:0002908) | 6.01906964 |
| 11 | Abnormality of the common coagulation pathway (HP:0010990) | 4.87793477 |
| 12 | Intrahepatic cholestasis (HP:0001406) | 4.65979107 |
| 13 | Xanthomatosis (HP:0000991) | 4.55702967 |
| 14 | Hypolipoproteinemia (HP:0010981) | 4.18618832 |
| 15 | Hyperlipoproteinemia (HP:0010980) | 4.01561709 |
| 16 | Spontaneous abortion (HP:0005268) | 3.94648610 |
| 17 | Nephritis (HP:0000123) | 3.92194030 |
| 18 | Hypercholesterolemia (HP:0003124) | 3.88674813 |
| 19 | Hemorrhage of the eye (HP:0011885) | 3.74734122 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 3.45719566 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36205226 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.32354181 |
| 23 | Menorrhagia (HP:0000132) | 3.28610277 |
| 24 | Abnormality of the intrinsic pathway (HP:0010989) | 3.27508896 |
| 25 | Purpura (HP:0000979) | 3.25582913 |
| 26 | Vascular calcification (HP:0004934) | 3.23756700 |
| 27 | Fat malabsorption (HP:0002630) | 3.21256010 |
| 28 | Mitral stenosis (HP:0001718) | 3.18922157 |
| 29 | Epidermoid cyst (HP:0200040) | 2.90480973 |
| 30 | Cardiovascular calcification (HP:0011915) | 2.86846417 |
| 31 | Gingival bleeding (HP:0000225) | 2.86829116 |
| 32 | Hepatocellular carcinoma (HP:0001402) | 2.63569778 |
| 33 | Thrombophlebitis (HP:0004418) | 2.56254205 |
| 34 | Acanthocytosis (HP:0001927) | 2.50261247 |
| 35 | Myocardial infarction (HP:0001658) | 2.47297431 |
| 36 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.46717612 |
| 37 | Small epiphyses (HP:0010585) | 2.44605552 |
| 38 | Abnormality of carpal bone ossification (HP:0006257) | 2.42794330 |
| 39 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.28424675 |
| 40 | Rickets (HP:0002748) | 2.24325058 |
| 41 | Skin nodule (HP:0200036) | 2.22130191 |
| 42 | Hypophosphatemic rickets (HP:0004912) | 2.19360374 |
| 43 | Abnormal tarsal ossification (HP:0008369) | 2.19159467 |
| 44 | Osteomalacia (HP:0002749) | 2.14924374 |
| 45 | Arthropathy (HP:0003040) | 2.12471602 |
| 46 | Pulmonary embolism (HP:0002204) | 2.09452092 |
| 47 | Flat acetabular roof (HP:0003180) | 2.06793551 |
| 48 | Protrusio acetabuli (HP:0003179) | 2.03998867 |
| 49 | Deep venous thrombosis (HP:0002625) | 10.5174220 |
| 50 | Cholecystitis (HP:0001082) | 1.95741871 |
| 51 | Abnormal gallbladder physiology (HP:0012438) | 1.95741871 |
| 52 | Abnormality of methionine metabolism (HP:0010901) | 1.93091148 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 1.90950831 |
| 54 | Hydroxyprolinuria (HP:0003080) | 1.90950831 |
| 55 | Facial shape deformation (HP:0011334) | 1.90011044 |
| 56 | Potter facies (HP:0002009) | 1.90011044 |
| 57 | Hyperglycinemia (HP:0002154) | 1.89074806 |
| 58 | Abnormality of glycine metabolism (HP:0010895) | 1.88480044 |
| 59 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.88480044 |
| 60 | Peritonitis (HP:0002586) | 1.88178628 |
| 61 | Esophageal varix (HP:0002040) | 1.87540152 |
| 62 | Hyperglycinuria (HP:0003108) | 1.85936715 |
| 63 | Hyperammonemia (HP:0001987) | 1.85421631 |
| 64 | Abnormality of the Achilles tendon (HP:0005109) | 1.84906700 |
| 65 | Abnormal ossification of hand bones (HP:0005921) | 1.84487026 |
| 66 | Abnormal hand bone ossification (HP:0010660) | 1.82348051 |
| 67 | Increased serum pyruvate (HP:0003542) | 1.80461514 |
| 68 | Bifid scrotum (HP:0000048) | 1.80296368 |
| 69 | Poikilocytosis (HP:0004447) | 1.77971136 |
| 70 | Broad alveolar ridges (HP:0000187) | 1.75435262 |
| 71 | Abnormal delivery (HP:0001787) | 1.74503047 |
| 72 | Cholelithiasis (HP:0001081) | 1.73999913 |
| 73 | Vaginal fistula (HP:0004320) | 1.73006998 |
| 74 | Enlarged kidneys (HP:0000105) | 1.72292685 |
| 75 | Asymmetry of the thorax (HP:0001555) | 1.70537128 |
| 76 | Abnormality of glycolysis (HP:0004366) | 1.67071825 |
| 77 | Hyperbilirubinemia (HP:0002904) | 1.66626599 |
| 78 | Steatorrhea (HP:0002570) | 1.65297088 |
| 79 | Generalized aminoaciduria (HP:0002909) | 1.65293031 |
| 80 | Elevated alkaline phosphatase (HP:0003155) | 1.64928946 |
| 81 | Amyloidosis (HP:0011034) | 1.64849823 |
| 82 | Epiphyseal dysplasia (HP:0002656) | 1.63614632 |
| 83 | Epistaxis (HP:0000421) | 1.61277079 |
| 84 | Broad palm (HP:0001169) | 1.60200899 |
| 85 | Joint swelling (HP:0001386) | 1.60192858 |
| 86 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.58646921 |
| 87 | Abnormal gallbladder morphology (HP:0012437) | 1.58643709 |
| 88 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.58603634 |
| 89 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.57366497 |
| 90 | Abnormality of the nasal septum (HP:0000419) | 1.57236593 |
| 91 | Delayed CNS myelination (HP:0002188) | 1.56959369 |
| 92 | Biconcave vertebral bodies (HP:0004586) | 1.56423026 |
| 93 | Gout (HP:0001997) | 1.54892261 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 1.53574401 |
| 95 | Cerebral aneurysm (HP:0004944) | 1.52721727 |
| 96 | Neonatal death (HP:0003811) | 1.51472903 |
| 97 | Flared iliac wings (HP:0002869) | 1.51129969 |
| 98 | Pigmentary retinal degeneration (HP:0001146) | 1.50813107 |
| 99 | Hypoglycemic coma (HP:0001325) | 1.50771069 |
| 100 | Back pain (HP:0003418) | 1.49824042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 7.00839286 |
| 2 | FGFR3 | 4.37916020 |
| 3 | ERN1 | 3.43164369 |
| 4 | ICK | 3.32644662 |
| 5 | RIPK1 | 3.19989434 |
| 6 | WNK4 | 2.76592114 |
| 7 | TRIB3 | 2.75195619 |
| 8 | CDK12 | 2.53763418 |
| 9 | PDGFRA | 2.39859496 |
| 10 | SIK1 | 2.35411627 |
| 11 | PIK3CA | 2.03624005 |
| 12 | TYRO3 | 1.91725464 |
| 13 | AKT3 | 1.80719640 |
| 14 | FGFR2 | 1.79674327 |
| 15 | EPHA3 | 1.71959594 |
| 16 | PKN2 | 1.65088843 |
| 17 | DDR2 | 1.58439643 |
| 18 | LATS2 | 1.54525333 |
| 19 | RET | 1.52693174 |
| 20 | FGFR1 | 1.48944351 |
| 21 | MST1R | 1.48826078 |
| 22 | ERBB2 | 1.41314878 |
| 23 | WNK1 | 1.30512399 |
| 24 | TGFBR2 | 1.30004436 |
| 25 | PRKAA2 | 1.29657203 |
| 26 | TYK2 | 1.26703743 |
| 27 | MAPK11 | 1.22514899 |
| 28 | EPHA2 | 1.21670616 |
| 29 | MET | 1.21380287 |
| 30 | NTRK3 | 1.19230589 |
| 31 | EEF2K | 1.18484679 |
| 32 | PDPK1 | 1.15555649 |
| 33 | DYRK1B | 1.12516203 |
| 34 | MAP3K2 | 1.11975681 |
| 35 | LATS1 | 1.10321797 |
| 36 | JAK1 | 1.02538213 |
| 37 | CDC42BPA | 1.00250347 |
| 38 | SIK2 | 0.99241826 |
| 39 | EPHB1 | 0.92332866 |
| 40 | SGK223 | 0.87650578 |
| 41 | SGK494 | 0.87650578 |
| 42 | LMTK2 | 0.87112425 |
| 43 | MAP3K3 | 0.83342475 |
| 44 | MAPKAPK3 | 0.82949775 |
| 45 | IRAK3 | 0.82721623 |
| 46 | MAP3K7 | 0.81717381 |
| 47 | MTOR | 0.80140424 |
| 48 | SGK1 | 0.79352258 |
| 49 | FER | 0.79067209 |
| 50 | PDK1 | 0.75535697 |
| 51 | MAP2K6 | 0.75507183 |
| 52 | NEK9 | 0.73956945 |
| 53 | PTK2 | 0.73188587 |
| 54 | PRKACG | 0.71057240 |
| 55 | SGK3 | 0.70892236 |
| 56 | SMG1 | 0.68690619 |
| 57 | PDGFRB | 0.68109395 |
| 58 | NLK | 0.65201880 |
| 59 | PRKAA1 | 0.64585265 |
| 60 | NTRK1 | 0.63141456 |
| 61 | PTK6 | 0.61126270 |
| 62 | MAP3K1 | 0.60910034 |
| 63 | MARK2 | 0.59472098 |
| 64 | EIF2AK1 | 0.55642186 |
| 65 | CDK7 | 0.51050853 |
| 66 | EPHA4 | 0.49775423 |
| 67 | CSNK1E | 0.48436187 |
| 68 | FGR | 0.48379527 |
| 69 | SGK2 | 0.47941378 |
| 70 | IGF1R | 0.47449239 |
| 71 | SRC | 0.46334213 |
| 72 | MAP3K6 | 0.45402745 |
| 73 | RPS6KB1 | 0.44809875 |
| 74 | STK39 | 0.44184515 |
| 75 | CSF1R | 0.43947399 |
| 76 | CAMK4 | 0.43561757 |
| 77 | STK38 | 0.42032820 |
| 78 | NTRK2 | 0.39836677 |
| 79 | JAK2 | 0.39728915 |
| 80 | MAPK3 | 0.37671066 |
| 81 | NEK6 | 0.37409109 |
| 82 | RPS6KA3 | 0.36340718 |
| 83 | PRKCZ | 0.33131647 |
| 84 | MATK | 0.32388177 |
| 85 | MAPK10 | 0.31436238 |
| 86 | KSR2 | 0.31173263 |
| 87 | PRKG1 | 0.30180465 |
| 88 | ZAP70 | 0.29780867 |
| 89 | CAMK1D | 0.28824000 |
| 90 | GSK3A | 0.28771549 |
| 91 | MAPK1 | 0.26446617 |
| 92 | MAPKAPK2 | 0.26290613 |
| 93 | CDK6 | 0.25004647 |
| 94 | CSNK1D | 0.24294313 |
| 95 | MAPK15 | 0.23859403 |
| 96 | BRSK1 | 0.22976833 |
| 97 | MELK | 0.21883924 |
| 98 | NME1 | 0.21747453 |
| 99 | ERBB4 | 0.21575257 |
| 100 | BRD4 | 0.19922433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 5.15841845 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.84262452 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.97386414 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.88108562 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.87072085 |
| 6 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.76164627 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71897303 |
| 8 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.57711368 |
| 9 | Retinol metabolism_Homo sapiens_hsa00830 | 2.56185794 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32737472 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.27585138 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.24803325 |
| 13 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.21061447 |
| 14 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.20062135 |
| 15 | Histidine metabolism_Homo sapiens_hsa00340 | 2.15736198 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.15521522 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.03386247 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02584055 |
| 19 | Bile secretion_Homo sapiens_hsa04976 | 1.95428801 |
| 20 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.93279509 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.84438840 |
| 22 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.75875656 |
| 23 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.74548682 |
| 24 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.66420461 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.62896073 |
| 26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.58217819 |
| 27 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.56430450 |
| 28 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.52072039 |
| 29 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.49781171 |
| 30 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.49286190 |
| 31 | ABC transporters_Homo sapiens_hsa02010 | 1.49158461 |
| 32 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.44379085 |
| 33 | Prion diseases_Homo sapiens_hsa05020 | 1.42940118 |
| 34 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.42113429 |
| 35 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35567907 |
| 36 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.31793218 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23721641 |
| 38 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.20360099 |
| 39 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.19035637 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.12565014 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 1.08676642 |
| 42 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.08202950 |
| 43 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.07153491 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 0.98318629 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98199667 |
| 46 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.97310007 |
| 47 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.88295076 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86721388 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.85038044 |
| 50 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.84743586 |
| 51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.83879823 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.82456713 |
| 53 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81433459 |
| 54 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.80157560 |
| 55 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77457326 |
| 56 | Carbon metabolism_Homo sapiens_hsa01200 | 0.75401762 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73539204 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.69197733 |
| 59 | Pertussis_Homo sapiens_hsa05133 | 0.67436374 |
| 60 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.66661827 |
| 61 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63092926 |
| 62 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.62470321 |
| 63 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58342004 |
| 64 | Insulin resistance_Homo sapiens_hsa04931 | 0.50971538 |
| 65 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.44991560 |
| 66 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.43453514 |
| 67 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41833681 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38754664 |
| 69 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.38289665 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36454239 |
| 71 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.33326057 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.29561402 |
| 73 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29014676 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.26693990 |
| 75 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24459098 |
| 76 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.20513174 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.18918354 |
| 78 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.15066929 |
| 79 | Amoebiasis_Homo sapiens_hsa05146 | 0.13321659 |
| 80 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.11803975 |
| 81 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.11639077 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.11009169 |
| 83 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.11006686 |
| 84 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.09293902 |
| 85 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.08938511 |
| 86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.08525546 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.05348322 |
| 88 | Sulfur relay system_Homo sapiens_hsa04122 | 0.05329124 |
| 89 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.04221382 |
| 90 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.03870573 |
| 91 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.03388239 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.03250285 |
| 93 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.00591209 |
| 94 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1083080 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.1045971 |
| 96 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.0782737 |
| 97 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.0723381 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0637910 |
| 99 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0232369 |
| 100 | Circadian rhythm_Homo sapiens_hsa04710 | -0.0071446 |

